Alpha-synuclein and Parkinson's disease
Golbe, L.I.
Advances in Neurology 91: 165-174
2003
ISSN/ISBN: 0091-3952 PMID: 12442675 Document Number: 557313
Document emailed within 1 workday
Related Documents
Oczkowska, A.; Kozubski, W.; Dorszewska, J. 2014: Alpha-synuclein in Parkinson's disease Przeglad Lekarski 71(1): 26-32Iwatsubo, T. 2002: Alpha-synuclein and Parkinson's disease SEIKAGAKU. Journal of Japanese Biochemical Society 74(6): 477-482
Polymeropoulos, M.H. 1998: Autosomal dominant Parkinson's disease and alpha-synuclein Annals of Neurology 44(3 Suppl 1): S63-S64
Polymeropoulos, M.H.; Lavedan, C.; Leroy, E.; Ide, S.E.; Dehejia, A.; Dutra, A.; Pike, B.; Root, H.; Rubenstein, J.; Boyer, R.; Stenroos, E.S.; Chandrasekharappa, S.; Athanassiadou, A.; Papapetropoulos, T.; Johnson, W.G.; Lazzarini, A.M.; Duvoisin, R.C.; Di Iorio, G.; Golbe, L.I.; Nussbaum, R.L. 1997: Mutation in the alpha-synuclein gene identified in families with Parkinson's disease Science 276(5321): 2045-2047
Hattori, N.; Machida, Y.; Noda, K. 2005: Pathogenesis of Parkinson's disease: a common pathway between alpha-synuclein and parkin and the mechanism of Lewy bodies formation Rinsho Shinkeigaku 45(11): 905-907
Takeda, A.; Hashimoto, M.; Mallory, M.; Sundsumo, M.; Hansen, L.; Sisk, A.; Masliah, E. 1998: Abnormal distribution of the non-Abeta component of Alzheimer's disease amyloid precursor/alpha-synuclein in Lewy body disease as revealed by proteinase K and formic acid pretreatment Laboratory Investigation; a Journal of Technical Methods and Pathology 78(9): 1169-1177
Mochizuki, H.; Yamada, M.; Mizuno, Y. 2006: Alpha-synuclein overexpression model Journal of Neural Transmission. Supplementum 2006(70): 281-284
Jensen, P.H.; Gai, W.P. 2001: Alpha-synuclein. Axonal transport, ligand interaction and neurodegeneration Advances in Experimental Medicine and Biology 487: 129-134
Sweet, R.D.; Lee, J.E.; McDowell, F. 1971: Alpha-methyldopa as an adjunct to levodopa treatment of Parkinson's disease Transactions of the American Neurological Association 96: 59-65
Sadekov, R.A. 2000: The influence of alpha-dihydroergocryptine derivatives on psychomotor manifestations in Parkinson disease Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 100(12): 43-45
Wang, Y.; Lü, C.; Ye, Z. 2002: Alpha-synuclein immunoreactivity and ultrastructural study of glial cytoplasmic inclusions in multiple system atrophy Chinese Medical Journal 115(10): 1491-1495
Masliah, E.; Rockenstein, E.; Veinbergs, I.; Mallory, M.; Hashimoto, M.; Takeda, A.; Sagara, Y.; Sisk, A.; Mucke, L. 2000: Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders Science 287(5456): 1265-1269
Glasgow, G.L.; Henley, J.W.; Willoughby, E.W. 1974: L-alpha-methyldopa hydrazine (Carbidopa) combined with L-dopa in the treatment of Parkinson's disease Australian and New Zealand Journal of Medicine 4(4): 373-378
Jiménez Jiménez, F.J.; Ladero Quesada, J.M. 1990: An experimental model of Parkinson disease caused by a neurotoxin: implications in the clinical aspects and the etiology of Parkinson disease Medicina Clinica 94(15): 585-595
Tanasanvimon, S.; Ayuthaya, N.I.N.; Phanthumchinda, K. 2007: Modified Parkinson's Disease Sleep Scale (MPDSS) in Thai Parkinson's disease patients Journal of the Medical Association of Thailand 90(11): 2277-2283
Hattori, N. 2004: Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease Rinsho Shinkeigaku 44(4-5): 241-262
Sale, P.; De Pandis, M.F.; Vimercati, S.L.; Sova, I.; Foti, C.; Tenore, N.; Fini, M.; Stocchi, F.; Albertini, G.; Franceschini, M.; Galli, M. 2013: The relation between Parkinson's disease and ageing. Comparison of the gait patterns of young Parkinson's disease subjects with healthy elderly subjects European Journal of Physical and Rehabilitation Medicine 49(2): 161-167
Bakinovskiĭ, L.V.; Gomtsian, A.R.; Baĭramova, N.E.; Kochetkov, N.K. 1985: Synthesis of oligosaccharide fragments of O-specific polysaccharides of Shigella flexneri. III. Synthesis of the tetrasaccharide Glc alpha 1-3Rha alpha 1-2(Glc alpha 1-3)Rha alpha 1-OMe and the pentasaccharide GlcNAc beta 1-2(Glc alpha 1-3)Rha alpha 1-2(Glc alpha 1-3)Rha alpha 1-OMe Bioorganicheskaia Khimiia 11(5): 655-661
Tsvetkova, I.V.; Karpova, E.A.; Voznyĭ, I.V.; Zolotukhina, T.V.; Biriukov, V.B.; Semiachkina, A.N. 1991: Use of 4-methylumbelliferryl-alpha-L-iduronide and 4-trifluoromethylumbelliferryl-alpha-L-iduronide for detecting alpha-L-iduronidase deficiencies in human tissue and for rapid prenatal diagnosis of Hurler disease Voprosy Meditsinskoi Khimii 37(1): 74-77
Mastaglia, F.L.; Masters, C.L.; Beyreuther, K.; Kakulas, B.A. 1989: Deposition of Alzheimer's disease amyloid (A4) protein in the cerebral cortex in Parkinson's disease Progress in Clinical and Biological Research 317: 475-484